Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy

DOI10.1016/J.JTBI.2022.111394MaRDI QIDQ2678792zbMATH OpenOpenAlexFDO

Authors Brock D. Sherlock, Adelle C. F. Coster

Publication date 24 January 2023

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.jtbi.2022.111394

zbMATH Keywords

mathematical modellingoncolytic virusoptimisationparameter inferencetreatment outcome

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Recommendations

• Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model
• Multiscale modelling of cancer response to oncolytic viral therapy
• Modeling treatment of cancer using oncolytic virotherapy with saturated incidence
• On a three-dimensional and two four-dimensional oncolytic viro-therapy models
• Ultimate tumor dynamics and eradication using oncolytic virotherapy
• The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• A mathematical model verifying potent oncolytic efficacy of M1 virus
• Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: a mathematical approach

Cites work

• A family of embedded Runge-Kutta formulae
• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• Modeling and analysis of a virus that replicates selectively in tumor cells
• ODE models for oncolytic virus dynamics
• Oncolytic virotherapy for tumours following a Gompertz growth law
• Optimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approach
• Population models with singular equilibrium
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

Cited in

(7)

• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• The replicability of oncolytic virus: defining conditions in tumor virotherapy
• Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
• Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus
• On the treatment of melanoma: a mathematical model of oncolytic virotherapy
• Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses
• Optimal control of virotherapy in a tumor model

This page was built for publication: Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2678792)